Clinical ResearchEconomic Impact of Same-Day Home Discharge After Uncomplicated Transradial Percutaneous Coronary Intervention and Bolus-Only Abciximab Regimen
Under an Elsevier user license
open archive
Key Words
cost
percutaneous coronary intervention
same-day discharge
transradial
Abbreviations and Acronyms
CHUM
Centre Hospitalier de l'Université de Montréal
DRG
diagnostic-related grouping
IUCPQ
Institut Universitaire de Cardiologie et de Pneumologie de Québec
MI
myocardial infarction
NIRRU
Niveau d'Intensité Relative des Ressources Utilisées
PCI
percutaneous coronary intervention
RAMQ
Régie de l'Assurance Maladie du Québec
Cited by (0)
This study was supported by the Cardiovascular Health Network of the Fonds de la Recherche en Santé du Québec (FRSQ), Canada. Drs. Rinfret and Bertrand are research scholars from FRSQ. Dr. Rinfret is a consultant for Abbott Vascular. Dr. Lachaine has received research grants from Pfizer Canada, Abbott Canada, Shire, Lundeck Theratechnologies, and Novartis. Dr. Cohen has received grant support from Eli Lilly, Daiichi-Sankyo, AstraZeneca, and Boehringer Ingelheim. Dr. Bertrand has provided consulting services for Cordis. All other authors have reported that they have no relationships to disclose.
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.